ConvergEx Global Transition Management

Clare Piper of ConvergEx Group explains how algorithmic trading can give transition managers an edge

Global Pensions gathered a panel of experts to discuss the strengths and weaknesses of transition management

UK - GlaxoSmithKline's £900m ($1.5bn) buy-in deal last year would not have been possible without transition managers, said Martin Mannion, director of pensions finance, investments and risk.